510(k) Report

FDA applicant

Spd Swiss Precision Diagnostics GmbH

Geneva, CH4 decisions2021–20242 recalls

FDA records 4 decisions for Spd Swiss Precision Diagnostics GmbH (Geneva, CH) from 2021 to 2024: 4 510(k) clearances. All are in product code LCX (Kit, Test, Pregnancy, Hcg, Over The Counter). Since 2016 its 510(k)s took a median of 343 days from receipt to decision, against 264 for FDA’s reviews in the same codes and years. Its devices cite 3 predicates, 0 of them its own earlier devices. 2 recalls are linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical chemistry panel, where it files most

How often FDA has decided Spd Swiss Precision Diagnostics GmbH’s devices, and how often a recall has named them.

FDA decisions per year

1in 2024

2021: 12022: 22024: 1
2021high 2 (2022) · low 0 (2023)2026

2026 so far, outlined.

Recalls per year

1in 2023

2022: 12023: 1
2021high 1 (2022) · low 0 (2021)2026

Class I Class II/III not classified

FIG. 1 — Spd Swiss Precision Diagnostics GmbH by year, 2021–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Spd Swiss Precision Diagnostics GmbH’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report